Enhanced brain targeting and improved Alzheimer's disease therapy via intranasal delivery of Ginsenoside F1-loaded mixed micelles
- 13 February 2026
- journal article
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 262, 115551
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, India
This publication has 26 references indexed in Scilit:
- Permeability of triamcinolone acetonide, released from mucoadhesive films, through a buccal mucosa-mimetic barrier: Permeapad™Dental Materials, 2024
- Comparison of pharmacological activity and safety of different stereochemical configurations of borneol: L-borneol, D-borneol, and synthetic borneolBiomedicine & Pharmacotherapy, 2023
- Development of dexamethasone-loaded mixed polymeric micelles for nasal deliveryEuropean Journal of Pharmaceutical Sciences, 2021
- Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: An opportunity to develop new CNS drugsEuropean Journal of Medicinal Chemistry, 2021
- Assessing the viability of Soluplus® self-assembled nanocolloids for sustained delivery of highly hydrophobic lapatinib (anticancer agent): Optimisation and in-vitro characterisationColloids and Surfaces B: Biointerfaces, 2020
- An Overview of Drug Delivery Systems2019
- Polymeric mixed micelles as nanomedicines: Achievements and perspectivesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2017
- Micellar and structural stability of nanoscale amphiphilic polymers: Implications for anti-atherosclerotic bioactivityBiomaterials, 2016
- Polymeric Micelles: Recent Advancements in the Delivery of Anticancer DrugsPharmaceutical Research, 2015
- Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer's diseaseInternational Journal of Pharmaceutics, 2014